GENEVA, July 18 -- IQURE PHARMA INC. filed a patent application (EP2026/050311) for “POSITIVE ALLOSTERIC MODULATOR (PAM) OF THE EAAT2/GLT-1 GLUTAMATE TRANSPORTER FOR USE IN THE TREATMENT OR PREVENTION OF DRAVET SYNDROME”. With publication no. WO/2026/150001, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: A61K 31/4015
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....